References
- Butt NM, Lambert J, Ali S, Beer PA, Cross NC, Duncombe A, et al. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017; 176:553–72.
- Tefferi A, Patnaik MM, Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br J Haematol. 2006; 133:468–92.
- Andersen CL, Siersma VD, Hasselbalch HC, Lindegaard H, Vestergaard H, Felding P, et al. Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death. Am J Hematol. 2013; 88:843–7.
- Kuang FL. Approach to patients with Eosinophilia. Med Clin North Am. 2020; 104:1–14.
- Andersen CL, Siersma VD, Hasselbalch HC, Vestergaard H, Mesa R, Felding P, et al. Association of the blood eosinophil count with hematological malignancies and mortality. Am J Hematol. 2015; 90:225–9.
- Brigden M, Graydon C. Eosinophilia detected by automated blood cell counting in ambulatory North American outpatients. Incidence and clinical significance. Arch Pathol Lab Med. 1997; 121:963–7.
- Chaipokam J. Correlation of Eosinophilia in routine blood samples and clinical manifestationsin Sakon Nakhon Hospital. J Sakon Nakhon Hosp. 2018; 21:194–202.
- Triteeraprapab S, Nuchprayoon I. Eosinophilia, anemia and parasitism in a rural region of northwest Thailand. Southeast Asian J Trop Med Public Health. 1998; 29:584–90.
- Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol. 2012; 49:149–59. doi: 10.1053/j.seminhematol.2012.01.006
- Falchi L, Verstovsek S. Eosinophilia in hematologic disorders. Immunol Allergy Clin North Am. 2015; 35:439–52.
- Guo C, Bochner BS. Workup for eosinophilia. Allergy Asthma Proc. 2019; 40:429–32.
- Nordic MPN Study Group. Care program for the diagnosis and treatment of eosinophilia 3rd version [Internet]. 2018 [cited 2011 Jul 10]. Available from: http://www.nmpn.org/index.php/guidelines/18-care-program-for-the-diagnosis-and-treatment-of-eosinophilia-3rd-version-may-2018/file
- Roufosse F, Weller PF. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol. 2010; 126:39–44.
- Makkar A, Rohtagi A, Goel A, Sharma SK, Garg S, Narayan S, et al. A study of clinical profile and spontaneous course of eosinophilia. JK Sci. 2005; 7:199–201.
- Wardlaw AJ, Wharin S, Aung H, Shaffu S, Siddiqui S. The causes of a peripheral blood eosinophilia in a secondary care setting. Clin Exp Allergy. 2021; 51:902–14.
- Page KR, Zenilman J. Eosinophilia in a patient from South America. JAMA. 2008; 299:437–44.
- Meltzer E, Percik R, Shatzkes J, Sidi Y, Schwartz E. Eosinophilia among returning travelers: a practical approach. Am J Trop Med Hyg. 2008; 78:702–9.
- Triteeraprapab S, Thamapanyawat B, Nuchprayoon I. Eosinophilia with low prevalence of parasitism in a rural area of Maha Sarakham province after annual mass treatment with mebendazole and albendazole. Chula Med J. 2000; 44:423–31.
- Kobayashi S, Inokuma S, Setoguchi K, Kono H, Abe K. Incidence of peripheral blood eosinophilia and the threshold eosinophile count for indicating hypereosinophilia-associated diseases. Allergy. 2002; 57:950–6.
- Wongsaroj T, Nithikathkul C, Rojkitikul W, Nakai W, Royal L, Rammasut P. National survey of helminthiasis in Thailand. Asian Biomed (Res Rev News). 2014; 8:779–83.
- Tarafder MR, Carabin H, Joseph L, Balolong E Jr, Olveda R, McGarvey ST. Estimating the sensitivity and specificity of Kato-Katz stool examination technique for detection of hookworms, Ascaris lumbricoides and Trichuris trichiura infections in humans in the absence of a ‘gold standard’. Int J Parasitol. 2010; 40:399–404.
- Checkley AM, Chiodini PL, Dockrell DH, Bates I, Thwaites GE, Booth HL, et al. Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management. J Infect. 2010; 60:1–20.
- Ustianowski A, Zumla A. Eosinophilia in the returning traveler. Infect Dis Clin North Am. 2012; 26:781–9.
- Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of strongyloides infection. Am J Trop Med Hyg. 1995; 53:248–50.
- Chai J-Y, Jung B-K, Hong S-J. Albendazole and mebendazole as anti-parasitic and anti-cancer agents: an update. Korean J Parasitol. 2021; 59:189–225.
- Suputtamongkol Y, Premasathian N, Bhumimuang K, Waywa D, Nilganuwong S, Karuphong E, et al. Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. PLoS Negl Trop Dis. 2011; 5:e1044.
- Sade K, Mysels A, Levo Y, Kivity S. Eosinophilia: a study of 100 hospitalized patients. Eur J Intern Med. 2007; 18:196–201.
- Chanswangphuwana C, Uaprasert N, Moonla C, Rojnuckarin P. Causes and outcomes of hypereosinophilia in a tropical country. Asian Pac J Allergy Immunol. 2021. doi: 10.12932/AP-221220-1021
- Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000; 121 Suppl:S113–32.
- Klion AD. How I treat hypereosinophilic syndromes. Blood. 2009; 114:3736–41.